A method for brain tumor classification from mri images using deep learning and image enhancement techniques
2019
0 views
0 downloads
Advisor: Dr. Öğr. Üyesi Ercan Avşar
Abstract (EN)
Magnetic resonance imaging (MRI) is a useful method for diagnosis of tumors in human brain. In this work, MRI images have been analyzed to detect the regions containing tumor and classify these regions into three different tumor categories: meningioma, glioma, and pituitary. Deep learning is a relatively recent and powerful method for image classification tasks. Therefore, faster Region-based Convolutional Neural Networks (faster R-CNN), a deep learning method, has been utilized in this study. A publicly available dataset containing 3,064 MRI brain images (708 meningioma, 1426 glioma, 930 pituitary) of 233 patients is used for training and testing of the classifier. It has been shown that faster R-CNN method can yield an accuracy of 93.14% which is higher than the related work using the same dataset. Keywords: Deep Learning, Convolutional Neural Network, Faster R-CNN, Classification, Brain Tumor
Author
Dr. Kerem Salçın
Institution
How to Cite
Kerem Salçın (Master Thesis). A method for brain tumor classification from mri images using deep learning and image enhancement techniques, 2019, Çukurova University.
Keywords
License
Tüm Hakları Saklıdır
This work is shared under the specified license terms.
More theses from Çukurova University
- Investigation of the relationship between the burnout levels and perceptions of organizational climate of preschool teachers(2021)
- Temel Weitzenböck türevleri(2022)
- Evaluation of online teaching processes in the context of lecturers' online teaching skills and strategies: A vocational college case(2022)
- The prevalence of olive leaf spot (Spilocaea oleginea) disease in olive orchards in Hatay province and identification of inoculum sources responsible for infections(2022)
- The new meaning of contemporary library and an investigation on interior design(2022)
- Factors affecting prognosis in pediatric patients with autosomal dominant polycystic kidney disease(2022)
